Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

Cited In for PubMed (Select 18753937)

1.

Magnitude and Predictors of Anti-Retroviral Treatment (ART) Failure in Private Health Facilities in Addis Ababa, Ethiopia.

Teshome Yimer Y, Yalew AW.

PLoS One. 2015 May 6;10(5):e0126026. doi: 10.1371/journal.pone.0126026. eCollection 2015.

2.

Optimal Treatment Strategies in the Context of 'Treatment for Prevention' against HIV-1 in Resource-Poor Settings.

Duwal S, Winkelmann S, Schütte C, von Kleist M.

PLoS Comput Biol. 2015 Apr 30;11(4):e1004200. doi: 10.1371/journal.pcbi.1004200. eCollection 2015 Apr.

3.

Effectiveness of first-line antiretroviral therapy in the IPEC cohort, Rio de Janeiro, Brazil.

Cardoso SW, Luz PM, Velasque L, Torres T, Coelho L, Freedberg KA, Veloso VG, Walensky RP, Grinsztejn B.

AIDS Res Ther. 2014 Sep 1;11:29. doi: 10.1186/1742-6405-11-29. eCollection 2014.

4.

Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda.

Goodall RL, Dunn DT, Pattery T, van Cauwenberge A, Nkurunziza P, Awio P, Ndembi N, Munderi P, Kityo C, Gilks CF, Kaleebu P, Pillay D; DART Virology Group and Trial Teams.

J Antimicrob Chemother. 2014 Jul;69(7):1938-44. doi: 10.1093/jac/dku052. Epub 2014 Mar 14.

5.
6.

Pharmacy and self-report adherence measures to predict virological outcomes for patients on free antiretroviral therapy in Tamil Nadu, India.

McMahon JH, Manoharan A, Wanke CA, Mammen S, Jose H, Malini T, Kadavanu T, Jordan MR, Elliott JH, Lewin SR, Mathai D.

AIDS Behav. 2013 Jul;17(6):2253-9. doi: 10.1007/s10461-013-0436-x.

7.

Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, Kenya.

Ferreyra C, Yun O, Eisenberg N, Alonso E, Khamadi AS, Mwau M, Mugendi MK, Alvarez A, Velilla E, Flevaud L, Arnedo M, Dalmau D, Roddy P, Bernasconi A, Palma PP.

PLoS One. 2012;7(11):e49834. doi: 10.1371/journal.pone.0049834. Epub 2012 Nov 21.

8.

Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South Africa.

Levison JH, Orrell C, Losina E, Lu Z, Freedberg KA, Wood R.

Antivir Ther. 2011;16(6):853-61. doi: 10.3851/IMP1819.

9.

Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives?

Braithwaite RS, Nucifora KA, Yiannoutsos CT, Musick B, Kimaiyo S, Diero L, Bacon MC, Wools-Kaloustian K.

J Int AIDS Soc. 2011 Jul 30;14:38. doi: 10.1186/1758-2652-14-38.

10.

Treatment switching in South Indian patients on HAART: what are the predictors and consequences?

Chandy S, Singh G, Heylen E, Gandhi M, Ekstrand ML.

AIDS Care. 2011 May;23(5):569-77. doi: 10.1080/09540121.2010.525607.

11.

Antiretroviral medication adherence and the development of class-specific antiretroviral resistance.

Gardner EM, Burman WJ, Steiner JF, Anderson PL, Bangsberg DR.

AIDS. 2009 Jun 1;23(9):1035-46. doi: 10.1097/QAD.0b013e32832ba8ec. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk